Pediatrix Medical Group, Inc. SEC filings MD

Pediatrix Medical Group, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Jun 2, 2009. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Pediatrix Medical Group, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Sep 14, 2026 —
4 Insider transaction Sep 14, 2026 Sep 10, 2026
144 Notice of proposed sale Sep 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Sep 3, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Sep 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 3, 2026 —
4 Insider transaction Aug 18, 2026 Aug 14, 2026
144 Notice of proposed sale Aug 14, 2026 —
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 24, 2026 Jul 21, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jul 15, 2026 Jul 15, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 14, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
3 Initial insider ownership Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
S-8 Employee stock plan registration May 21, 2026 —
4 Insider transaction May 14, 2026 May 13, 2026
4 Insider transaction May 14, 2026 May 13, 2026
144 Notice of proposed sale May 13, 2026 —
4 Insider transaction May 13, 2026 May 11, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 11, 2026 May 7, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 7, 2026 May 7, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
DEFA14A Additional proxy material Apr 17, 2026 —
ARS Annual report to shareholders Mar 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 27, 2026 —
DEF 14A Proxy statement Mar 27, 2026 Mar 25, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
10-K Annual report Feb 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 17, 2025 —
4 Insider transaction Nov 10, 2025 Nov 6, 2025
144 Notice of proposed sale Nov 6, 2025 —
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
4 Insider transaction Aug 21, 2025 Aug 19, 2025
8-K Current report
Regulation FD disclosure, Other events
Aug 18, 2025 Aug 18, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
3 Initial insider ownership Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2025 —
3 Initial insider ownership Jul 1, 2025 Jul 1, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 1, 2025 Jul 1, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 3, 2025 —
4 Insider transaction May 27, 2025 May 23, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 8, 2025
4 Insider transaction May 12, 2025 May 9, 2025
8-K Current report
Shareholder vote results
May 8, 2025 May 8, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
8-K Current report
Material agreement
Apr 18, 2025 Apr 15, 2025
ARS Annual report to shareholders Mar 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 28, 2025 —
DEF 14A Proxy statement Mar 28, 2025 Mar 26, 2025
4 Insider transaction Mar 7, 2025 Mar 6, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
4 Insider transaction Feb 26, 2025 Feb 25, 2025
144 Notice of proposed sale Feb 21, 2025 —
10-K Annual report Feb 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 20, 2025 Feb 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
4 Insider transaction Jan 14, 2025 Jan 12, 2025
8-K Current report
Officer or director change
Jan 14, 2025 Jan 12, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Officer or director change
Dec 5, 2024 Nov 29, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Nov 14, 2024 Nov 13, 2024
SC 13G Ownership over 5% (passive) Nov 13, 2024 —
144 Notice of proposed sale Nov 13, 2024 —
4 Insider transaction Nov 12, 2024 Nov 8, 2024
144 Notice of proposed sale Nov 8, 2024 —
144 Notice of proposed sale Nov 4, 2024 —
10-Q Quarterly report Nov 1, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 1, 2024 Nov 1, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 31, 2024 —
3 Initial insider ownership Oct 4, 2024 Oct 1, 2024
4 Insider transaction Sep 3, 2024 Aug 30, 2024
144 Notice of proposed sale Aug 30, 2024 —
4 Insider transaction Aug 29, 2024 Aug 27, 2024
144 Notice of proposed sale Aug 27, 2024 —
4 Insider transaction Aug 13, 2024 Aug 9, 2024
144 Notice of proposed sale Aug 9, 2024 —
144 Notice of proposed sale Aug 9, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations, Officer or director change
Aug 6, 2024 Aug 1, 2024
8-K Current report
Officer or director change
Jun 17, 2024 Jun 17, 2024
SC 13G/A Amended ownership over 5% (passive) Jun 10, 2024 —
4 Insider transaction Jun 4, 2024 Jun 1, 2024
4 Insider transaction Jun 4, 2024 Jun 1, 2024
4 Insider transaction Jun 4, 2024 Jun 1, 2024
4 Insider transaction Jun 4, 2024 Jun 1, 2024
4 Insider transaction Jun 4, 2024 Jun 1, 2024
8-K Current report
Regulation FD disclosure
May 30, 2024 May 30, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
8-K Current report
Shareholder vote results
May 9, 2024 May 9, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
8-K Current report
Material agreement
Apr 25, 2024 Apr 19, 2024
ARS Annual report to shareholders Mar 28, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 28, 2024 —
DEF 14A Proxy statement Mar 28, 2024 May 9, 2024
4 Insider transaction Mar 14, 2024 Mar 13, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
10-K Annual report Feb 20, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 20, 2024 Feb 20, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
SC 13G Ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 22, 2024 —
4 Insider transaction Dec 15, 2023 Dec 14, 2023
4 Insider transaction Dec 15, 2023 Dec 14, 2023
144 Notice of proposed sale Dec 14, 2023 —
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
UPLOAD Letter from the SEC Aug 16, 2023 —
CORRESP Letter to the SEC Aug 8, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
UPLOAD Letter from the SEC Jul 27, 2023 —
4 Insider transaction Jun 16, 2023 Jun 14, 2023
144 Notice of proposed sale Jun 14, 2023 —
4 Insider transaction Jun 8, 2023 Jun 7, 2023
4 Insider transaction Jun 2, 2023 Jun 1, 2023
4 Insider transaction Jun 2, 2023 Jun 1, 2023
4 Insider transaction May 26, 2023 May 25, 2023
144 Notice of proposed sale May 24, 2023 —
4 Insider transaction May 22, 2023 May 18, 2023
144 Notice of proposed sale May 19, 2023 —
144 Notice of proposed sale May 18, 2023 —
4 Insider transaction May 15, 2023 May 11, 2023
4 Insider transaction May 15, 2023 May 11, 2023
4 Insider transaction May 15, 2023 May 11, 2023
4 Insider transaction May 15, 2023 May 11, 2023
4 Insider transaction May 15, 2023 May 11, 2023
4 Insider transaction May 15, 2023 May 11, 2023
4 Insider transaction May 15, 2023 May 11, 2023
4 Insider transaction May 15, 2023 May 15, 2023
4 Insider transaction May 15, 2023 May 12, 2023
3 Initial insider ownership May 15, 2023 May 12, 2023
144 Notice of proposed sale May 12, 2023 —
8-K Current report
Shareholder vote results
May 11, 2023 May 11, 2023
144 Notice of proposed sale May 10, 2023 —
SC 13G/A Amended ownership over 5% (passive) May 10, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
May 4, 2023 May 4, 2023
10-Q Quarterly report May 2, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 2, 2023 May 2, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Hospitals (SIC 8060)
Listed as
MD (NYSE)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Sunrise, FL
SEC filer status
Large accelerated filer
SEC CIK
893949
Former names
MEDNAX, INC. (until Jun 21, 2022); PEDIATRIX MEDICAL GROUP INC (until Jan 2, 2009)

Other Services-Hospitals companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.